Royal Bank of Canada’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,718
| Closed | -$38K | – | 7300 |
|
|
2019
Q4 | $38K | Buy |
9,718
+7,310
| +304% | +$34.3K | ﹤0.01% | 5579 |
|
|
2019
Q3 | $12K | Sell |
2,408
-2,374
| -50% | -$13.3K | ﹤0.01% | 5729 |
|
|
2019
Q2 | $29K | Buy |
4,782
+3,103
| +185% | +$16.5K | ﹤0.01% | 5544 |
|
|
2019
Q1 | $9K | Sell |
1,679
-1,714
| -51% | -$17.7K | ﹤0.01% | 6063 |
|
|
2018
Q4 | $47K | Sell |
3,393
-1,139
| -25% | -$19.2K | ﹤0.01% | 5146 |
|
|
2018
Q3 | $88K | Buy |
4,532
+1,973
| +77% | +$42K | ﹤0.01% | 4933 |
|
|
2018
Q2 | $66K | Buy |
2,559
+1,602
| +167% | +$37.4K | ﹤0.01% | 5028 |
|
|
2018
Q1 | $20K | Sell |
957
-30,750
| -97% | -$717K | ﹤0.01% | 5460 |
|
|
2017
Q4 | $636K | Sell |
31,707
-311
| -1% | -$6.12K | ﹤0.01% | 3612 |
|
|
2017
Q3 | $663K | Sell |
32,018
-3,248
| -9% | -$54.9K | ﹤0.01% | 3574 |
|
|
2017
Q2 | $521K | Buy |
35,266
+7,056
| +25% | +$118K | ﹤0.01% | 3630 |
|
|
2017
Q1 | $451K | Buy |
28,210
+13,640
| +94% | +$197K | ﹤0.01% | 3731 |
|
|
2016
Q4 | $183K | Buy |
14,570
+14,327
| +5,896% | +$267K | ﹤0.01% | 4540 |
|
|
2016
Q3 | $7K | Sell |
243
-27,455
| -99% | -$921K | ﹤0.01% | 5905 |
|
|
2016
Q2 | $969K | Buy |
27,698
+27,498
| +13,749% | +$864K | ﹤0.01% | 3133 |
|
|
2016
Q1 | $5K | Sell |
200
-5,714
| -97% | -$168K | ﹤0.01% | 5940 |
|
|
2015
Q4 | $203K | Buy |
5,914
+4,362
| +281% | +$136K | ﹤0.01% | 4510 |
|
|
2015
Q3 | $45K | Sell |
1,552
-65
| -4% | -$2.78K | ﹤0.01% | 5192 |
|
|
2015
Q2 | $72K | Buy |
1,617
+1,124
| +228% | +$42.3K | ﹤0.01% | 5025 |
|
|
2015
Q1 | $17K | Sell |
493
-15,839
| -97% | -$431K | ﹤0.01% | 5414 |
|
|
2014
Q4 | $447K | Buy |
+16,332
| New | +$396K | ﹤0.01% | 3683 |
|
Other funds holding DPLO
Royal Bank of Canada's DPLO Position: Q1 2020 in Review
Royal Bank of Canada sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 9,718 shares — an estimated $38K sold.
Royal Bank of Canada first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $969K in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Royal Bank of Canada reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Royal Bank of Canada sold 9,718 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $38K.
- Royal Bank of Canada first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Royal Bank of Canada's DIPLOMAT PHARMACY, INC. position peaked at $969K in Q2 2016.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.